相关实验视频
Updated: Jun 6, 2025

08:45
Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 25, 2016
23.5K
发现铁胺酸衍生物作为快速恢复的催眠药,没有上腺皮层抑制
Jin Zhu1, Xue Jiang1, Zongzheng Li1
1Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, School of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China.
Bioorganic chemistry
|November 30, 2024
概括
新的铁胺酸衍生物 (TETs) 被开发为快速恢复麻醉剂. 与埃托米达相比,TET-13显示出强烈的麻醉作用,与上腺皮质抑制显著减少.
科学领域:
- 麻醉学和药理学 麻醉学和药理学
- 药用化学 医学化学
背景情况:
- 静脉麻醉剂,如埃托米达,对于手术至关重要,但会导致上腺抑制.
- 开发具有快速恢复和最小副作用的新型麻醉剂至关重要.
研究的目的:
- 设计和合成铁胺酸衍生物 (TETs) 作为潜在的快速恢复催眠剂.
- 评估这些衍生物的麻醉疗效和安全性,特别是侧重于上腺皮层抑制.
主要方法:
- 一系列铁胺酸衍生物 (TET-1-TET-14) 的合成.
- 在大鼠血中对TET-13代谢的药理动力学分析.
- 在小鼠和老鼠中评估麻醉效能 (ED50).
- 评估GABA-A受体结合亲和力和积极的全osteric调制.
- 在体内研究来比较TET-13和埃托米达特之间的恢复时间和上腺皮层抑制.
主要成果:
- 与埃托米达 (T1/2 = 26 分钟) 相比,TET-13 的新陈代谢显著加快 (T1/2 = 0.48 分钟).
- TET-13在动物中显示出强烈的麻醉作用 (ED50=小鼠0.48毫克/千克,大鼠0.69毫克/千克),恢复时间较短.
- TET-13作为GABA-A受体 (EC50 = 5.65μM) 的阳性全调节剂,类似于etomidate.
- 在同等剂量下,TET-13引起的上腺皮质抑制明显低于埃托米达.
- 与埃托米达相比,连续输液研究显示TET-13的恢复和行走时间较短.
结论:
- 铁胺酸衍生物,特别是TET-13,代表了一类有前途的快速作用麻醉剂.
- TET-13提供了一个有利的形状,具有快速的恢复和减少的上腺皮层抑制,解决了etomidate的关键限制.
- 这些发现支持开发具有更高安全性和疗效的新型催眠剂,用于手术麻醉.
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146
Sedatives and Hypnotics: Overview
279
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
279
Sedatives and Hypnotics Drugs: Barbiturates
196
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
196
Sedatives and Hypnotics Drugs: Benzodiazepines
194
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
194
CNS Depressants: Barbiturates and Benzodiazepines
224
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
224
Management of Insomnia
231
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
231

